Lessons From The Vioxx Fiasco

"What a mess. Weeks after Merck & Co. (MRK ) yanked its blockbuster painkiller Vioxx off the market, the furor is still raging. How could a drug get to $2.5 billion in annual sales despite evidence that it caused heart problems?" [BusinessWeek Online]